01 50Smart & Biggar
02 2Takeda Canada Inc.
01 21327010
02 22375201
03 22407208
04 22436825
05 62463690
06 62499574
07 62570916
08 62671369
09 22701704
10 62702356
11 62737851
12 62771725
01 28DEXLANSOPRAZOLE
02 24Dexlansoprazole
01 28CAPSULE (DELAYED RELEASE)
02 24Capsule, Delayed Release
01 22011-02-15
02 22020-06-15
03 22021-04-26
04 22021-05-15
05 22021-11-30
06 62022-10-16
07 182023-10-15
08 62025-06-01
09 62028-10-10
10 62029-03-09
Patent Expiration Date : 2025-06-01
Date Granted : 2013-06-11
Brand Name : DEXILANT
Patent Number : 2570916
Filing Date : 2005-06-01
Strength per Unit : 30 mg
Dosage Form : Capsule, Delayed Release
Human Or VET : Human
Route of Administration : ORAL, NASOGASTRIC
Patent Expiration Date : 2025-06-01
Date Granted : 2013-06-11
Patent Expiration Date : 2021-04-26
Date Granted : 2010-08-17
Brand Name : DEXILANT
Patent Number : 2407208
Filing Date : 2001-04-26
Strength per Unit : 30 mg
Dosage Form : Capsule, Delayed Release
Human Or VET : Human
Route of Administration : ORAL, NASOGASTRIC
Patent Expiration Date : 2021-04-26
Date Granted : 2010-08-17
Patent Expiration Date : 2029-03-09
Date Granted : 2011-05-10
Brand Name : DEXILANT
Patent Number : 2671369
Filing Date : 2009-03-09
Strength per Unit : 30 mg
Dosage Form : Capsule, Delayed Release
Human Or VET : Human
Route of Administration : ORAL, NASOGASTRIC
Patent Expiration Date : 2029-03-09
Date Granted : 2011-05-10
Patent Expiration Date : 2025-06-01
Date Granted : 2013-06-11
Brand Name : DEXILANT
Patent Number : 2570916
Filing Date : 2005-06-01
Strength per Unit : 60 mg
Dosage Form : Capsule, Delayed Release
Human Or VET : Human
Route of Administration : ORAL, NASOGASTRIC
Patent Expiration Date : 2025-06-01
Date Granted : 2013-06-11
Patent Expiration Date : 2021-04-26
Date Granted : 2010-08-17
Brand Name : DEXILANT
Patent Number : 2407208
Filing Date : 2001-04-26
Strength per Unit : 60 mg
Dosage Form : Capsule, Delayed Release
Human Or VET : Human
Route of Administration : ORAL, NASOGASTRIC
Patent Expiration Date : 2021-04-26
Date Granted : 2010-08-17
Patent Expiration Date : 2021-11-30
Date Granted : 2011-01-18
Brand Name : DEXILANT
Patent Number : 2436825
Filing Date : 2001-11-30
Strength per Unit : 30 mg
Dosage Form : Capsule, Delayed Release
Human Or VET : Human
Route of Administration : ORAL, NASOGASTRIC
Patent Expiration Date : 2021-11-30
Date Granted : 2011-01-18
Patent Expiration Date : 2021-05-15
Date Granted : 2011-09-06
Brand Name : DEXILANT
Patent Number : 2701704
Filing Date : 2001-05-15
Strength per Unit : 30 mg
Dosage Form : Capsule, Delayed Release
Human Or VET : Human
Route of Administration : ORAL, NASOGASTRIC
Patent Expiration Date : 2021-05-15
Date Granted : 2011-09-06
Patent Expiration Date : 2021-11-30
Date Granted : 2011-01-18
Brand Name : DEXILANT
Patent Number : 2436825
Filing Date : 2001-11-30
Strength per Unit : 60 mg
Dosage Form : Capsule, Delayed Release
Human Or VET : Human
Route of Administration : ORAL, NASOGASTRIC
Patent Expiration Date : 2021-11-30
Date Granted : 2011-01-18
Patent Expiration Date : 2021-05-15
Date Granted : 2011-09-06
Brand Name : DEXILANT
Patent Number : 2701704
Filing Date : 2001-05-15
Strength per Unit : 60 mg
Dosage Form : Capsule, Delayed Release
Human Or VET : Human
Route of Administration : ORAL, NASOGASTRIC
Patent Expiration Date : 2021-05-15
Date Granted : 2011-09-06
Patent Expiration Date : 2022-10-16
Date Granted : 2011-08-23
Brand Name : DEXILANT
Patent Number : 2463690
Filing Date : 2002-10-16
Strength per Unit : 30 mg
Dosage Form : Capsule, Delayed Release
Human Or VET : Human
Route of Administration : ORAL, NASOGASTRIC
Patent Expiration Date : 2022-10-16
Date Granted : 2011-08-23
